Quantcast

Latest Clinical trial Stories

2014-08-29 16:24:04

-- Clinical and preclinical programs remain on track SAN DIEGO, Aug. 29, 2014 /PRNewswire/ -- Mast Therapeutics, Inc. (NYSE MKT: MSTX), an emerging biopharmaceutical company, announced today that Santosh Vetticaden, Chief Medical Officer and Senior Vice President, will be leaving the Company, for personal reasons, in mid-September. Edwin L. Parsley, D.O., the Chief Medical Officer of Aires Pharmaceuticals, which Mast acquired earlier this year, will assume Dr. Vetticaden's former...

2014-08-29 08:24:27

Investor update call to be held Tuesday, September 2 VANCOUVER, British Columbia and MENLO PARK, Calif., Aug. 29, 2014 /PR Newswire/ -- DelMar Pharmaceuticals, Inc. (OTCQB: DMPI) ("DelMar" "the Company") today announced the filing of June 30, 2014 fiscal year-end financial statements. The Company recently changed its fiscal year end to June 30th in order to facilitate an application to list its common stock on a national securities exchange in the timeliest manner possible. DelMar's...

2014-08-28 23:07:25

Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, today announced that Kristen DeVito, Global Director Clinical Supply Services, and Chris Greco, Manager, Comparator and Ancillary Supplies, will present “Critical Path Sourcing Strategies for Active Control Clinical Trials” at the forthcoming US Clinical Trials Supply Conference, which takes place on the 9th – 10th...

2014-08-28 12:30:53

DENVER, Aug. 28, 2014 /PRNewswire/ -- Pharmatech initiated enrollment for its AccessPPM program after a two-year investment into this game-changing method for matching cancer patients to cancer clinical trials. Today, clinical trials target specific cancers, disease staging, and genetic mutations - which may be contributing factors for the cancer, in the first place. The challenge that the industry faces, is that this information may not be well known to the patient or even their...

2014-08-27 23:14:58

The research team at Avail Clinical is conducting new clinical studies in DeLand, FL. People who are living with fibromyalgia may qualify to participate if they are at least 18 years of age. DeLand, FL (PRWEB) August 27, 2014 *Anyone who is interested in learning more about the clinical trials being conducted in DeLand, FL can visit Avail Clinical Research on the web (http://www.availclinical.com) or contact them directly at (386) 785-2404. Fibromyalgia Over 5 million Americans are...

2014-08-27 23:14:55

The research team at Achieve Clinical is conducting a new clinical study in Birmingham, AL. People who are living with fibromyalgia may qualify to participate if they are at least 18 years of age. Birmingham, AL (PRWEB) August 27, 2014 *To find out more about this fibromyalgia clinical trial in Birmingham, AL, visit Achieve Clinical Research on the web (http://www.achieveclinical.com) or contact them directly at (205) 380-6434. For those who qualify: There is no cost to participate...

2014-08-27 23:07:36

Radiant Sage LLC, a provider of on-demand clinical trial imaging infrastructure solutions, today announced that it has been named to CIOReview’s list of 100 Most Promising Technology Companies. The CIOReview100 includes companies that are gaining momentum in the technology industry and making an impact. Belmont, Mass. (PRWEB) August 27, 2014 “We are honored to be named to this list of top technology vendors,” said Ven Thangaraj, CEO of Radiant Sage. “We are offering truly...

2014-08-27 08:24:05

MarketOptimizer.org adds new clinical trial report "Fatty Liver Disease Global Clinical Trials Review, H2, 2014" to its store. DALLAS, Aug. 27, 2014 /PRNewswire-iReach/ -- "Fatty Liver Disease Global Clinical Trials Review, H2, 2014 provides data on the Fatty Liver Disease clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Fatty Liver Disease. It includes an overview of the trial numbers and their recruitment status as per the site...

2014-08-26 23:04:51

Journal of Clinical Trial Results to Share Rare, Successful and Non-Successful Trial Results Philadelphia, PA (PRWEB) August 26, 2014 ERT, a leading global solution provider for high-quality patient safety and efficacy endpoint data collection, today announced that its President and CEO, Jeffrey S. Litwin, M.D. has been named editor-in-chief of MultiMedia LLC’s new peer-reviewed publication: Journal of Clinical Trial Results. The online, open-access publication serves researchers,...

2014-08-26 16:28:14

LONDON, Aug. 26, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:Diabetic Retinopathy Global Clinical Trials Review, H1, 2014http://www.reportbuyer.com/pharma_healthcare/research_rd/clinical_trials/diabetic_retinopathy_global_clinical_trials_review.htmlDiabetic Retinopathy Global Clinical Trials Review, H1, 2014SummaryGlobalData's clinical trial report, "Diabetic Retinopathy Global Clinical Trials Review, H1, 2014" provides data on the Diabetic Retinopathy...


Word of the Day
jument
  • A beast of burden; also, a beast in general.
'Jument' ultimately comes from the Latin 'jugum,' yoke.
Related